"Providing high quality care to patients from San Antonio, and from around the world, for more than 50 years"

During the past decade, Methodist Healthcare System of San Antonio conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 16 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 8 clinical trials were completed. i.e. 88.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist Healthcare System of San Antonio" #1 sponsor was "Children's Oncology Group" with 9 trials, followed by "Chimerix" with 3 trials sponsored, "National Cancer Institute (NCI)" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Boston Scientific Corporation" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist Healthcare System of San Antonio" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "Biostatistical Consulting, Inc." with 1 trials as a collaborator, "Cancer Prevention Research Institute of Texas" with 1 trials as a collaborator, "Children's Oncology Group" with 1 trials as a collaborator and "HealthCore-NERI" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Methodist Healthcare System of San Antonio" are "Leukemia" (4 trials), "Brain and Central Nervous System Tumors" (3 trials), "Sarcoma" (3 trials), "Unspecified Childhood Solid Tumor, Protocol Specific" (3 trials) and "Cytomegalovirus Infections" (2 trials). Many other conditions were trialed in "Methodist Healthcare System of San Antonio" in a lesser frequency.

Most popular intervention types in "Methodist Healthcare System of San Antonio" are "Drug" (31 trials), "Biological" (9 trials), "Procedure" (8 trials), "Device" (7 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "filgrastim" (4 trials), "etoposide" (3 trials), "radiation therapy" (3 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Methodist Healthcare System of San Antonio" are 44 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Methodist Healthcare System of San Antonio". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Methodist Healthcare System of San Antonio, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Methodist Healthcare System of San Antonio, 6 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".